Skip to main content
. Author manuscript; available in PMC: 2012 Jul 3.
Published in final edited form as: Clin Colorectal Cancer. 2011 Apr 22;10(2):113–116. doi: 10.1016/j.clcc.2011.03.007

Table 3.

Common Adjuvant Regimens and Reasons for Excluding Oxaliplatin

Regimen Frequency (%)
Any 99
Contained Oxaliplatin 61
FOLFOX 54
5-FU/LV 19
Capecitabine 12
FLOX/CapOx 5
Infusional 5-FU/capecitabine Alone 2
Why No Oxaliplatin?
 Comorbidity 68
 Age 19